@FiercePharma: Spectrum rejigs sales ops after Allos buyout, to tout its 3-drug stable. Prep for new ones, too. More | Follow @FiercePharma
> Eli Lilly ($LLY) is injection $140 million into U.S. insulin pen production at a plant in Indianapolis. Item
> Teva Pharmaceutical Industries ($TEVA) reported revenue reached $5 billion in the third quarter, up 14% from $4.3 billion in the corresponding quarter in 2011. News
> Drug-mixing pharmacy Ameridose recalled its products Wednesday, after federal health inspectors asked the company to improve its sterility testing. Report (sub. req.)
> The EMA's Pharmacovigilance Risk Assessment Committee put diclofenac-containing medicines (non-steroidal anti-inflammatory drugs) under safety review in relation to their possible cardiovascular risks. Report
> In a plan to save €2.7 billion ($3.5 billion), the region of Madrid will introduce a one-euro surcharge for medical prescriptions next year. Story
> India's government may lift a ban on pharma firm-sponsored tours for doctors. Article
> Aurobindo Pharma soared more than 8% to Rs 171 on the Bombay Stock Exchange, driven by abbreviated new drug application approvals received from the U.S. FDA. News
@FierceMedDev: Michael Mahoney, Boston Scientific's new CEO, inherits a giant in transition on day one. More | Follow @FierceMedDev
@MarkHFierce: Advanced Cell Diagnostics pulled in $12 million in new Series B financing. More | Follow @MarkHFierce
@DamianFierce: It's campaign season, and medical device companies are donating big. Find out how and to whom in our report. More | Follow @DamianFierce
> Medtronic closes $816M buyout of Chinese devicemaker. News
> BD completes $730M sale of labware unit. Item
> Disgraced former head of defunct French breast implant maker freed from jail. Article
Biotech News
@FierceBiotech: Trending on FierceBiotech.com : The 2012 Biotech Graveyard. Special Report | Follow @FierceBiotech
@JohnCFierce: Medivir would like everyone to know that JNJ's hep C drug came from them. Alios outlicensed Vertex drug, but they've always been low profile. | Follow @JohnCFierce
@RyanMFierce: Sanofi deal bolsters Medidata in record quarter for revenue, boosts number of cloud customers in pharma. More | Follow @RyanMFierce
> Hurricane Sandy flooding wipes out years of drug research at NYU lab. Story
> Vertex partners with J&J, GlaxoSmithKline on new hep C combos. News
> FDA spurns new low-sodium drug from Cornerstone. Article
Vaccines News
@AlisonBFierce: In search of a lasting flu vaccine: Researchers work to find decades of protection with one shot. More | Follow @AlisonBFierce
> Health officials clash over whether to scrap malaria program. Item
> Mumps vaccine succumbs to face-to-face contact. Story
> U.K.'s HPA lands $6.4M for anthrax vaccine research. Article
> Study: Flu vaccine protects against heart attacks. More
Pharma Manufacturing News
> Lonza whacking 500 jobs, 400 at Swiss API plant. Story
> Compounder recall may make drug shortages more severe. News
> Novartis adding $500M biologics plant in Singapore. Report
> Boston-area pharma plant goes up for auction to pay debts. More
And Finally... A study from the Netherlands shows almost a third of women on asthma medications stop using them during the first few months of pregnancy, despite advice that a mother's uncontrolled asthma is more dangerous to the developing fetus than the drugs. More